The rationale of prevention of thrombosis by enhancing blood levels of single-chain urokinase-type plasminogen activator (scuPA)

article



Dooijewaard, G.

Boheemen, P.A. van

Binnema, D.J.

Kluft, C.
Chemicals/CAS: Tissue Plasminogen Activator, EC 3.4.21.68; Urinary Plasminogen Activator, EC 3.4.21.73
Topics










ProurokinaseBlood levelConference paperCardiovascular DiseasesFibrinolysisHumanModels, BiologicalModels, CardiovascularThrombosisTissue Plasminogen ActivatorUrinary Plasminogen Activator
TNO Identifier
231971
Repository link
https://resolver.tno.nl/uuid:0960b1b2-4982-4694-9153-8951011233c7
ISSN
00778923
Source
Annals of the New York Academy of Sciences, 667, pp. 278-280.
Pages
278-280
Files
To receive the publication files, please send an e-mail request to TNO Repository.